ArticleGut2000
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.
Article in Gut, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.Digestive diseases and sciences · 2004Trial
- Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord Blood.Journal of inflammation research · 2025Article
- The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review.Gut pathogens · 2021Review
- Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.Cells · 2019Review
- Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.Medicine · 2018Article
- Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.Journal of pediatric gastroenterology and nutrition · 2018Article
- Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.PloS one · 2018Article
- Antibody markers in the diagnosis of inflammatory bowel disease.World journal of gastroenterology · 2016Review
- Use of animal models in elucidating disease pathogenesis in IBD.Seminars in immunopathology · 2014Review
- Inflammatory bowel disease serology in Asia and the West.World journal of gastroenterology · 2013Article
- Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.Inflammatory bowel diseases · 2013Article
- Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes.Cell host & microbe · 2012Article
- ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.Digestive diseases and sciences · 2012Article
- Increased levels of anti-glycan antibodies in patients with cystic fibrosis.European journal of medical research · 2011Article
- Inflammation and gastrointestinal Candida colonization.Current opinion in microbiology · 2011Review
- Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2011Article
- Serum anti-Saccharomyces cerevisiae antibodies in Greek patients with Behcet's disease.Yonsei medical journal · 2011Article
- Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.Immunogenetics · 2009Article
- Article
- MAGI2 genetic variation and inflammatory bowel disease.Inflammatory bowel diseases · 2009Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundCrohn's disease is a familial disorder, and antiglycan antibodies to the cell wall mannan of Saccharomyces cerevisiae (ASCA) are highly correlated with Crohn's disease.
aimsTo determine whether there is a familial pattern for expression of serum levels of anti-mannan Ig, and whether this trait is expressed in clinically unaffected Crohn's disease family members.
methods349 patients with Crohn's disease, 87 Crohn's disease affected relatives, 333 inflammatory bowel disease (IBD) free relatives, 58 spouses, and 190 healthy control patients were studied. Serum IgG and IgA binding activity to S cerevisiae cell wall mannan was quantitated by ELISA.
resultsA high percentage of patients with Crohn's disease (51.9%) and affected family members (56.3%) were seropositive for anti-mannan Ig, compared with the normal control population (3.7%). Seropositive and seronegative phenotypes of Crohn's disease probands were correlated among all affected relatives, and this association was stronger in affected first degree relatives. Statistical intraclass correlations of quantitative anti-mannan Ig levels revealed significantly less variation within, rather than between families. A significant familial aggregation was observed for affected relatives; this was even stronger for unaffected relatives. While a significant familial aggregation was observed among unaffected siblings pairs, there was no significant correlation among marital pairs.
conclusionResults show that anti-mannan Ig in family members affected and unaffected with Crohn's disease is a familial trait for both affected and unaffected relatives. The lack of concordance in marital pairs indicates that familiality is due in part to a genetic factor or childhood environmental exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.